Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Wolf

I just wanted to refresh the pertinent info again to get an idea of where we'll stand one the case mgmt. conference happens........

Part of the plaintifs background arguement.......

AAs of April 30, 2009, a total of eleven reexamination proceedings had been initiated against the five MMP patents in the United States Patent and Trademark Office (“USPTO”). HTC has initiated at least three reexamination proceedings since the parties have filed their briefings with respect to the instant motion. Acer did not request any of the reexamination proceedings. Seven of the eleven reexaminations pending or completed as of April 30, 2009 were filed by defendant parties in a separate and unrelated suit brought by TPL. Every claim at issue in the instant action currently is pending reexamination or is the subject of a completed reexamination process. The USPTO has issued a final office action rejecting all of the claims of the ‘336 patent and has rejected the majority of the asserted claims of the ‘148 and ‘548 patents. The USPTO also has granted re-examination with respect to both the ‘890 and the ‘749 patents. Plaintiffs seek an indefinite stay of the instant proceedings pending the resolution of the reexamination proceedings.
s of April 30, 2009, a total of eleven reexamination proceedings had been initiated against the five MMP patents in the United States Patent and Trademark Office (“USPTO”). HTC has initiated at least three reexamination proceedings since the parties have filed their briefings with respect to the instant motion. Acer did not request any of the reexamination proceedings. Seven of the eleven reexaminations pending or completed as of April 30, 2009 were filed by defendant parties in a separate and unrelated suit brought by TPL. Every claim at issue in the instant action currently is pending reexamination or is the subject of a completed reexamination process. The USPTO has issued a final office action rejecting all of the claims of the ‘336 patent and has rejected the majority of the asserted claims of the ‘148 and ‘548 patents. The USPTO also has granted re-examination with respect to both the ‘890 and the ‘749 patents. Plaintiffs seek an indefinite stay of the instant proceedings pending the resolution of the reexamination proceedings.

And the date of Sept. 18th for a case management conference......

With the appearance of the 336 & the 584 being settled in our favor, the 890 & 749 probably won't be settled by Sept. 18th and has anyone an idea on the status of the 148?

Share
New Message
Please login to post a reply